Adjuvant prophylactic human papillomavirus (HPV) vaccination in patients treated for vulvar high-grade squamous intraepithelial lesions (vHSIL); a systematic review
Cell Reports
· Elsevier
Аннотация
Publication date: December 2026 Source: Vaccine: X, Volume 33 Author(s): Vera J.G.M. Vaessen, Ralf L.O. van de Laar, Nina van Gerwen, Heleen J. van Beekhuizen
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Биохимия, генетика и молекулярная биология (общие)»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Adjuvant prophylactic human papillomavirus (HPV) vaccination in patients treated for vulvar high-grade squamous intraepithelial lesions (vHSIL); a systematic review. // Cell Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2590136226001245?dgcid=rss_sd_all
Adjuvant prophylactic human papillomavirus (HPV) vaccination in patients treated for vulvar high-grade squamous intraepithelial lesions (vHSIL); a systematic review. Cell Reports. https://www.sciencedirect.com/science/article/pii/S2590136226001245?dgcid=rss_sd_all
“Adjuvant prophylactic human papillomavirus (HPV) vaccination in patients treated for vulvar high-grade squamous intraepithelial lesions (vHSIL); a systematic review.” Cell Reports.
@article{article11432,
title = {Adjuvant prophylactic human papillomavirus (HPV) vaccination in patients treated for vulvar high-grade squamous intraepithelial lesions (vHSIL); a systematic review},
journal = {Cell Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2590136226001245?dgcid=rss_sd_all}
}